We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News   Oct 19, 2017

 
Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma
 
 
 

RELATED ARTICLES

Major New Vulnerability of Childhood Leukemia Uncovered

News

A team of researchers has recently uncovered a major new vulnerability of mixed lineage leukemia.

READ MORE

Hunt for the Missing T-Cells in Glioblastoma Patients

News

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

READ MORE

Key Physical Properties of Giant Cancer Cells Revealed

News

First study on the physical properties of polyploidal cancer cells shows they are stiffer, larger, and move further.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE